31
Participants
Start Date
August 8, 2023
Primary Completion Date
May 2, 2033
Study Completion Date
May 2, 2033
Fazirsiran Injection
Fazirsiran will be injected subcutaneously.
Universitätsklinikum der RWTH Aachen, Aachen
Stanford Medicine Outpatient Center, Redwood City
UCSD Altman Clinical and Translational Research Institute, La Jolla
UF Clinical and Translational Science Institute, Gainesville
University Of Iowa Hospitals And Clinics, Iowa City
Medical University of South Carolina - Hollings Cancer Center - PPDS, Charleston
Medizinische Universitat Wien (Medical University of Vienna), Vienna
Hospital Nélio Mendonça, Funchal
Addenbrooke's Hospital, Cambridge
Royal Infirmary of Edinburgh - PPDS, Edinburgh
Lead Sponsor
Takeda
INDUSTRY